These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9036020)

  • 1. The 2nd NIEHS Predictive-Toxicology Evaluation Experiment: 30 chemical carcinogenicity bioassays.
    Environ Health Perspect; 1996 Oct; 104 Suppl 5():999-1112. PubMed ID: 9036020
    [No Abstract]   [Full Text] [Related]  

  • 2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogenicity predictions for a group of 30 chemicals undergoing rodent cancer bioassays based on rules derived from subchronic organ toxicities.
    Lee Y; Buchanan BG; Rosenkranz HS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1059-63. PubMed ID: 8933055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NIEHS Predictive-Toxicology Evaluation Project.
    Bristol DW; Wachsman JT; Greenwell A
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1001-10. PubMed ID: 8933048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of non-mammalian species in bioassays for carcinogenicity.
    Bunton TE
    IARC Sci Publ; 1999; (146):151-84. PubMed ID: 10353387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging challenges in toxicopathology: carcinogenic threshold of phenobarbital and proof of arsenic carcinogenicity using rat medium-term bioassays for carcinogens.
    Fukushima S; Morimura K; Wanibuchi H; Kinoshita A; Salim EI
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):225-9. PubMed ID: 15993454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods.
    Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):97-110. PubMed ID: 16352383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints.
    Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):83-96. PubMed ID: 16386343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of rodent carcinogenesis bioassays.
    Ward JM
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):212. PubMed ID: 18029286
    [No Abstract]   [Full Text] [Related]  

  • 12. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-aided rodent carcinogenicity prediction.
    Lagunin AA; Dearden JC; Filimonov DA; Poroikov VV
    Mutat Res; 2005 Oct; 586(2):138-46. PubMed ID: 16112600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can systems toxicology identify common biomarkers of non-genotoxic carcinogenesis?
    Plant N
    Toxicology; 2008 Dec; 254(3):164-9. PubMed ID: 18674585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
    Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for carcinogens: shift from animals to automation gathers steam--slowly.
    Schmidt C
    J Natl Cancer Inst; 2009 Jul; 101(13):910-2. PubMed ID: 19549960
    [No Abstract]   [Full Text] [Related]  

  • 19. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
    Shirai T; Hirose M; Ito N
    IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.